CytoMed Therapeutics (GDTC) Stock Chart & Stock Price History $2.12 -0.15 (-6.39%) Closing price 09/15/2025 03:57 PM EasternExtended Trading$2.10 -0.02 (-0.94%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CytoMed Therapeutics Stock Price Performance The CytoMed Therapeutics (GDTC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 41.67%, with a year-to-date return of -37.50%. In the past month, the stock has increased 18.06%, reflecting recent market activity. As of the latest close, CytoMed Therapeutics traded at $2.13 with a market cap of $0.00 and volume of 10,407 shares. Receive GDTC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytoMed Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+5.72%1 Month Performance+18.06%3 Month Performance+1.67%Year-To-Date Performance-37.50%1 Year Performance+41.67% GDTC Stock Chart for Tuesday, September, 16, 2025 GDTC Chart by TradingView CytoMed Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/15/2025$2.27$2.13-6.39%$2.28$2.1310,407 shs$0.0009/12/2025$2.01$2.27+12.94%$2.27$2.0064,587 shs$0.0009/11/2025$1.98$2.01+1.33%$2.06$1.9811,204 shs$0.0009/10/2025$1.87$1.98+6.31%$2.00$1.9216,813 shs$0.0009/09/2025$1.83$1.87+1.97%$1.96$1.8210,647 shs$0.0009/08/2025$1.92$1.83-4.69%$1.87$1.839,167 shs$0.0009/05/2025$1.90$1.92+1.05%$1.93$1.852,902 shs$0.0009/04/2025$1.96$1.90-2.81%$1.99$1.891,739 shs$0.0009/03/2025$2.01$1.96-2.49%$2.03$1.857,302 shs$21.39 million09/02/2025$2.03$2.01-1.23%$2.07$2.006,834 shs$0.00 Get the Latest News and Ratings for GDTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytoMed Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/01/2025$2.03$2.03$2.04$2.002,726 shs$0.0008/29/2025$2.03$2.03$2.04$2.002,726 shs$0.0008/28/2025$1.93$2.03+5.13%$2.03$2.009,835 shs$22.21 million08/27/2025$1.99$1.93-3.01%$2.01$2.01642 shs$0.0008/26/2025$1.96$1.99+1.58%$1.97$1.923,048 shs$0.0008/25/2025$1.85$1.96+6.00%$2.14$1.8753,179 shs$21.44 million08/22/2025$1.78$1.85+3.88%$1.85$1.799,980 shs$20.23 million08/21/2025$1.75$1.78+1.71%$1.78$1.734,592 shs$0.0008/20/2025$1.75$1.75$1.77$1.656,593 shs$0.0008/19/2025$1.78$1.75-1.41%$1.79$1.7213,266 shs$19.15 million08/18/2025$1.80$1.78-1.39%$1.80$1.7721,161 shs$0.0008/15/2025$1.77$1.80+1.69%$1.80$1.746,384 shs$0.00 Related Companies ATNFW Stock Chart LBPSW Stock Chart AEHAW Stock Chart AIMDW Stock Chart ALVOW Stock Chart ARAV Stock Chart ACABW Stock Chart BFRIW Stock Chart BTMDW Stock Chart BCTXW Stock Chart Receive GDTC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytoMed Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GDTC) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytoMed Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share CytoMed Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
